Randomized controlled trial of limited fasciotomy with injection of adipose graft for Dupuytren's disease

8Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Objective: Dupuytren's disease is a genetic disorder related to the proliferation of myofibroblasts. The pluripotent property of stem cells present in adipose tissue inhibits myofibroblast proliferation. Our study sought to evaluate the effect of stem cell-rich fat grafts in patients that underwent limited fasciotomy. Methods: We studied 45 patients, in a single-blind, prospective, randomized clinical trial. All patients underwent limited fasciotomy. In one group, fat graft was injected. Results: The total passive extension deficit results did not exhibit a significant difference. Fat group exhibited worse functional score at 6 months and 1 year postoperatively, such as higher complication rates (43%), when compared with control group (8%), and more pain at 6 weeks follow-up. Conclusion: Fat grafting associated with limited fasciotomy promotes worse functional results compared to conventional limited fasciotomy in the short term. However, long-term results and recurrence rates should be further assessed. Level of Evidence II, Prospective comparative study.

Cite

CITATION STYLE

APA

Sambuy, M. T. C., Nakamoto, H. A., Neto, R. B., Mattar, R., Rezende, M. R., & Wei, T. H. (2020). Randomized controlled trial of limited fasciotomy with injection of adipose graft for Dupuytren’s disease. Acta Ortopedica Brasileira, 28(4), 159–64. https://doi.org/10.1590/1413-785220202804233522

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free